Teicoplanin Therapeutic Drug Monitoring and Treatment Outcomes in Children With Gram-Positive Infections-Reference-Cited by-同舟云学术

Teicoplanin Therapeutic Drug Monitoring and Treatment Outcomes in Children With Gram-Positive Infections

Published:2021-02-05 Issue:5 Volume:10 Page:682-685
ISSN:2048-7207
Container-title:Journal of the Pediatric Infectious Diseases Society
language:en
Short-container-title:

Author:

Loane Georgia¹^ORCID,Gwee Amanda¹²³

Affiliation:

1. Department of General Medicine, The Royal Children’s Hospital Melbourne, Parkville, Victoria, Australia

2. Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia

3. Infectious Diseases Group, Murdoch Children’s Research Institute, Parkville, Victoria, Australia

Abstract

Abstract This is a retrospective audit of teicoplanin dosing, drug-level monitoring, and outcomes in 29 children who received 31 courses of teicoplanin. Our study of noncritically ill children showed that the majority (35/43, 81%) of trough concentrations were within the therapeutic range (10-30 mg/L) contrasting previous studies in children. Overall, 21 of the 24 (88%) children with Gram-positive infections achieved cure.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,General Medicine,Pediatrics, Perinatology and Child Health

Link

http://academic.oup.com/jpids/article-pdf/10/5/682/38360538/piab005.pdf

Reference19 articles.

1. Teicoplanin versus vancomycin for proven or suspected infection;Cavalcanti;Cochrane Database Syst Rev,2010

2. Treatment of endocarditis with teicoplanin: a retrospective analysis of 104 cases;Wilson;J Antimicrob Chemother,1996

3. Teicoplanin therapy for Staphylococcus aureus septicaemia: relationship between pre-dose serum concentrations and outcome;Harding;J Antimicrob Chemother,2000

4. Population pharmacokinetics of teicoplanin in children;Ramos-Martín;Antimicrob Agents Chemother,2014

5. Population pharmacokinetics and dosing optimization of teicoplanin in children with malignant haematological disease;Zhao;Br J Clin Pharmacol,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimal Teicoplanin Trough Concentration With Therapeutic Drug Monitoring in Children: A Systematic Review and Meta-analysis;Therapeutic Drug Monitoring;2024-07-09

2. Development and Validation of a High-Performance Liquid Chromatography With Ultraviolet Detection Method to Facilitate Therapeutic Monitoring of Teicoplanin Using Dried Blood Spots;Therapeutic Drug Monitoring;2024-06-18

3. Acute bacterial skin and skin structure infections in pediatric patients: potential role of dalbavancin;Expert Review of Anti-infective Therapy;2023-02-27

4. Optimal Use and Need for Therapeutic Drug Monitoring of Teicoplanin in Children: A Systematic Review;Journal of Korean Medical Science;2023